Skip to main content
Close up of a hand using a tablet Close up of a hand using a tablet

Latest News

Nine Drug Formularies In Canada List Evenity® For Reimbursement For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk Of Fracture

April 3, 2024

Amgen Canada has announced EVENITY’s (romosozumab) inclusion in public formularies, marking a significant step in osteoporosis care for postmenopausal women.

EVENITY has been listed for reimbursement on nine of Canada’s public formularies. With this announcement most postmenopausal women in Canada will be able to access this biologic treatment which received Health Canada approval in 2019.

Click here to visit AMGEN Canada and read the full release

To learn more about osteoporosis treatments visit https://osteoporosis.ca/treatments/


OC MAKES THE NEWS – RECENT ITEMS

Nine Drug Formularies In Canada List Evenity® For Reimbursement For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk Of Fracture

April 3, 2024
Latest News Nine Drug Formularies In Canada List Evenity® For Reimbursement For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk Of Fracture April 3, 2024 Amgen Canada has […]

IOF Welcomes Dr. Famida Jiwa as Chair of the Committee of National Societies

February 9, 2024
Latest News IOF Welcomes Dr. Famida Jiwa as Chair of the Committee of National Societies February 9, 2024 Following the elections held for the position of Chair of the International […]

Top 2023 Article on CMAJ.ca

January 29, 2024
Latest News Clinical Practice Guideline – Top 2023 Article on CMAJ.ca January 29, 2024 On October 10, 2023 a new guideline on the management of osteoporosis and fracture prevention was […]
© Osteoporosis Canada, 2024
Charitable Registration No. 89551 0931 RR 0001